No Detail Found!

Comparison of Efficacy of Teriparatide (Parathyroid Hormone 1-34) Alone and in Combination with Zoledronic Acid for Osteoporosis in Postmenopausal Women

Author(s)
Kang Wei First Department of Orthopadics, Changzhou Traditional Chinese Medicine Hospital, Nanjing University of Chinese Medicine,China
Yuxing Qu First Department of Orthopadics, Changzhou Traditional Chinese Medicine Hospital, Nanjing University of Chinese Medicine,China
Yi Gao First Department of Orthopadics, Changzhou Traditional Chinese Medicine Hospital, Nanjing University of Chinese Medicine,China
Yong Ma Department of Orthopedics and Traumatology, First Clinical Medical College, Nanjing University of Chinese Medicine, China
Abstract
The purpose of this study was to compare the e cacy of teriparatide (parathyroid hormone 1-34) alone and in combination with zoledronic acid (ZA) for the treatment of osteoporosis in postmenopausal women. Ninety-six patients were randomly equally divided into Groups A (n=48) and B (n=48). Group A was given parathyroid hormone 1-34 alone. Group B was treated with parathyroid hormone 1-34 plus ZA. Visual analogue scale (VAS) score, bone mineral density(BMD), serum osteopontin (OPN), and C-terminal cross-linking telopeptide of type I collagen (S-CTX) etc. were compared. After 6 months of treatment, VAS score, serum OPN and S-CTX levels in Group B were signi cantly lower than those inGroup A (p=0.001, p<0.001 and p<0.001, respectively); and BMD values of lumbar vertebrae L2-4, femoral neck and total hip bone in Group B were higher than those of Group A (p=0.002, p=0.028 and p<0.001, respectively). In conclusion, parathyroid hormone 1-34 plus ZA is more e ective than parathyroid hormone 1-34 alone in treating post postmenopausal osteoporosis.
Publication Details
Page(s) 240-242
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
Osteoporosis, Postmenopausal, Teriparatide (parathyroid hormone 1-34, Bone mineral density (BMD), Zoledronic acid (ZA)
0

Citations

0

Downloads

96

Views